SCHEMBL31035470

SCHEMBL31035470

CC(=O)c1cc(C)cc2c(=O)c(C)c(N3CCN(C(=O)OC(C)(C)C)CC3)oc12

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 2/20 0.40
KDR P35968 1/20 0.39
AKT1 P31749 1/20 0.39
AKT2 P31751 1/20 0.39
AKT3 Q9Y243 1/20 0.39
MAPT P10636 4/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
TSHR P16473 1/20 0.37
GPR119 Q8TDV5 4/20 0.36
LMNA P02545 2/20 0.36
ALDH1A1 P00352 2/20 0.36
PIK3CA P42336 2/20 0.36
CYP2C19 P33261 1/20 0.36
PTPN11 Q06124 1/20 0.36
BACE1 P56817 2/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31035298 0.84 AKT1 (0.45) CSF1RKDRAKT1AKT2AKT3
SCHEMBL31035555 0.83 AKT1 (0.45) CSF1RKDRAKT1AKT2AKT3
SCHEMBL31035139 0.81 AKT1 (0.46) AKT1AKT2AKT3SMN1; SMN2TSHR
SCHEMBL31035072 0.80 P2RY12 (0.48) AKT1AKT2AKT3MAPTALDH1A1
SCHEMBL23887230 0.79 AKT1 (0.56) AKT1AKT2AKT3PIK3CA
SCHEMBL31035207 0.79 PIK3CA (0.51) AKT1AKT2AKT3PIK3CA
SCHEMBL31035887 0.78 AKT1 (0.50) AKT1AKT2AKT3PIK3CA
SCHEMBL23887236 0.70 AKT1 (0.47) AKT1AKT2AKT3PIK3CA
SCHEMBL31035315 0.70 PIK3CA (0.61) AKT1AKT2AKT3SMN1; SMN2PIK3CA
SCHEMBL14598638 0.70 MAPT (0.54) MAPTMEN1KMT2ASMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4680612-A1 CHEMICAL COMPOUNDS AN2 Therapeutics, Inc. (US) 2026-01-21 EP disclosed
WO-2024192309-A1 CHEMICAL COMPOUNDS REACTIVE BIOSCIENCES, INC. (US) 2024-09-19 WO disclosed